SteelPeak Wealth LLC reduced its stake in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 6.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 435,144 shares of the company’s stock after selling 29,793 shares during the quarter. SteelPeak Wealth LLC’s holdings in Astrana Health were worth $15,478,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Farther Finance Advisors LLC raised its holdings in shares of Astrana Health by 730.1% during the 3rd quarter. Farther Finance Advisors LLC now owns 689 shares of the company’s stock worth $25,000 after acquiring an additional 606 shares during the period. Public Employees Retirement System of Ohio acquired a new position in shares of Astrana Health during the 2nd quarter valued at about $51,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Astrana Health in the second quarter valued at about $529,000. Fifth Third Bancorp grew its holdings in shares of Astrana Health by 4,855.4% in the first quarter. Fifth Third Bancorp now owns 12,438 shares of the company’s stock valued at $305,000 after purchasing an additional 12,187 shares during the period. Finally, First Citizens Bank & Trust Co. grew its holdings in shares of Astrana Health by 48.3% in the first quarter. First Citizens Bank & Trust Co. now owns 16,614 shares of the company’s stock valued at $407,000 after purchasing an additional 5,408 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.
Astrana Health Price Performance
NASDAQ:ASTH opened at $36.81 on Friday. Astrana Health, Inc. has a 52 week low of $18.08 and a 52 week high of $51.60. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 1.05. The company has a market capitalization of $2.05 billion, a P/E ratio of 44.89 and a beta of 1.03. The stock’s fifty day moving average is $37.28 and its two-hundred day moving average is $37.53.
Astrana Health (NASDAQ:ASTH – Get Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.34 by $0.46. The firm had revenue of $972.52 million for the quarter, compared to analyst estimates of $985.62 million. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The business’s revenue for the quarter was up 48.5% compared to the same quarter last year. During the same period in the prior year, the business posted $0.19 EPS. Equities analysts expect that Astrana Health, Inc. will post 1.36 EPS for the current year.
Analyst Ratings Changes
Several equities research analysts recently issued reports on the stock. Wall Street Zen cut shares of Astrana Health from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. TD Cowen increased their price target on shares of Astrana Health from $45.00 to $50.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Truist Financial increased their price target on shares of Astrana Health from $47.00 to $55.00 and gave the company a “buy” rating in a research note on Monday, August 10th. Weiss Ratings restated a “hold (c)” rating on shares of Astrana Health in a report on Thursday, August 27th. Finally, BTIG Research lifted their price target on shares of Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Eight equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Astrana Health presently has a consensus rating of “Moderate Buy” and an average price target of $49.88.
View Our Latest Report on Astrana Health
About Astrana Health
Astrana Health, Inc is a healthcare enablement company that helps physicians and other healthcare providers deliver coordinated, value-based care. The company works with medical groups, independent physician associations and healthcare organizations to manage patient populations, improve clinical outcomes and coordinate services across primary, specialty and post-acute care settings.
Astrana Health provides care-management programs, population-health analytics, technology solutions and administrative support designed to help providers manage risk-based reimbursement arrangements.
Featured Articles
- Five stocks we like better than Astrana Health
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTH – Free Report).
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
